88 related articles for article (PubMed ID: 8951192)
21. Biomembrane affinity chromatographic analysis of nitrobenzylthioinosine binding to the reconstituted human red cell nucleoside transporter.
Haneskog L; Lundqvist A; Lundahl P
J Mol Recognit; 1998; 11(1-6):58-61. PubMed ID: 10076807
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
[TBL] [Abstract][Full Text] [Related]
24. A new fluorescent probe for the equilibrative inhibitor-sensitive nucleoside transporter. 5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine (SAENTA)-chi 2-fluorescein.
Wiley JS; Brocklebank AM; Snook MB; Jamieson GP; Sawyer WH; Craik JD; Cass CE; Robins MJ; McAdam DP; Paterson AR
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):667-72. PubMed ID: 1996965
[TBL] [Abstract][Full Text] [Related]
25. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine.
Rongen GA; Lenders JW; Lambrou J; Willemsen JJ; Van Belle H; Thien T; Smits P
Hypertension; 1996 Apr; 27(4):933-8. PubMed ID: 8613271
[TBL] [Abstract][Full Text] [Related]
26. Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
Sinclair CJ; Powell AE; Xiong W; LaRivière CG; Baldwin SA; Cass CE; Young JD; Parkinson FE
Br J Pharmacol; 2001 Nov; 134(5):1037-44. PubMed ID: 11682452
[TBL] [Abstract][Full Text] [Related]
27. Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters.
Jarvis SM; Thorn JA; Glue P
Br J Pharmacol; 1998 Apr; 123(8):1587-92. PubMed ID: 9605565
[TBL] [Abstract][Full Text] [Related]
28. Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat.
Cleton A; de Greef HJ; Edelbroek PM; Voskuyl RA; Danhof M
Br J Pharmacol; 1999 Dec; 128(8):1651-8. PubMed ID: 10588919
[TBL] [Abstract][Full Text] [Related]
29. Identification of nucleoside transport binding sites in the human myocardium.
Abd-Elfattah AS; Hoehner J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):105-10. PubMed ID: 9546636
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
Cox EH; Kuipers JA; Danhof M
Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
[TBL] [Abstract][Full Text] [Related]
31. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).
Vickers MF; Mani RS; Sundaram M; Hogue DL; Young JD; Baldwin SA; Cass CE
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):21-32. PubMed ID: 10085223
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and pharmacodynamics of dexamethasone after intravenous administration in camels: effect of dose.
Al Katheeri NA; Wasfi IA; Lambert M; Saeed A
Vet Res Commun; 2004 Aug; 28(6):525-42. PubMed ID: 15509026
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic/pharmacodynamic evaluation of the NHE inhibitor eniporide.
Kovar A; Peters T; Beier N; Derendorf H
J Clin Pharmacol; 2001 Feb; 41(2):139-48. PubMed ID: 11210393
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men.
Barrett JS; Murphy G; Peerlinck K; De Lepeleire I; Gould RJ; Panebianco D; Hand E; Deckmyn H; Vermylen J; Arnout J
Clin Pharmacol Ther; 1994 Oct; 56(4):377-88. PubMed ID: 7955799
[TBL] [Abstract][Full Text] [Related]
35. Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells.
Boumah CE; Hogue DL; Cass CE
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):987-96. PubMed ID: 1472012
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
Hammond JR
Mol Pharmacol; 1991 Jun; 39(6):771-9. PubMed ID: 2051991
[TBL] [Abstract][Full Text] [Related]
37. Nucleoside translocation in sheep reticulocytes and fetal erythrocytes: a proposed model for the nucleoside transporter.
Jarvis SM; Young JD
J Physiol; 1982 Mar; 324():47-66. PubMed ID: 6284922
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats.
van Schaick EA; de Greef HJ; Langemeijer MW; Sheehan MJ; IJzerman AP; Danhof M
Br J Pharmacol; 1997 Oct; 122(3):525-33. PubMed ID: 9351510
[TBL] [Abstract][Full Text] [Related]
39. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
Vyas S; Ahmadi B; Hammond JR
Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
[TBL] [Abstract][Full Text] [Related]
40. Effect of detergents on ligand binding and translocation activities of solubilized/reconstituted nucleoside transporters.
Hammond JR; Zarenda M
Arch Biochem Biophys; 1996 Aug; 332(2):313-22. PubMed ID: 8806740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
